🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

AdaptHealth expands stock incentive plan, transitions to annual director elections

Published 21/06/2024, 21:52
AHCO
-

AdaptHealth Corp. (NASDAQ:AHCO), a provider of home healthcare services, announced significant corporate governance changes and enhancements to its stock incentive plan following its annual meeting of stockholders on Thursday.

The shareholders approved an amendment to increase the number of shares reserved under the company's Amended and Restated 2019 Stock Incentive Plan by 8,350,000 shares. This move, which also extends the plan's termination date to just before its tenth anniversary, aims to bolster incentives for key officers and employees.

In a bid to align with best practices for corporate governance, AdaptHealth's stockholders also voted in favor of transitioning from a classified board structure to annual elections for directors. This change will be phased in over three years, culminating at the 2026 annual meeting when the entire board will stand for election on an annual basis.

The company's Third Amended and Restated Certificate of Incorporation was amended to reflect these changes, including the adoption of new Delaware law provisions regarding officer exculpation, which limit the liability of certain company officers.

Additionally, the shareholders ratified the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, and approved, in a non-binding advisory vote, the compensation paid to AdaptHealth's named executive officers.

In other recent news, AdaptHealth Corp. has reported a significant Q1 growth. The company saw a 6.2% increase in non-acquired revenue and an 18% increase in adjusted EBITDA year-over-year. Suzanne Foster has been appointed as the new CEO and under her leadership, the company plans to continue its growth trajectory and reduce debt. Despite some operational challenges, AdaptHealth remains committed to its financial objectives for the year.

AdaptHealth's full-year guidance remains unchanged with revenue expected between $3.25 billion and $3.35 billion. The company anticipates that Q2 will be softer due to tough comparisons in the diabetes and sleep categories. However, it sees potential growth in the sleep business and is considering outsourcing partnerships to reduce costs.

InvestingPro Insights

As AdaptHealth Corp. (NASDAQ:AHCO) implements significant corporate governance changes, real-time data and InvestingPro Tips provide an additional layer of insight for investors evaluating the company's prospects. According to InvestingPro, management has been actively repurchasing shares, a sign that could be interpreted as confidence in the company's future performance. Additionally, while analysts have revised their earnings expectations downwards for the upcoming period, there is a consensus that AdaptHealth will become profitable this year, which aligns with the company's growth trajectory in the home healthcare sector.

InvestingPro Data highlights a market capitalization of $1.43 billion and a forward-looking P/E ratio for the last twelve months as of Q1 2024 at 17.06, indicating potential for future earnings growth. The company has also experienced a notable price increase over the last six months, with a 57.9% total return, which may interest investors looking for momentum in stock performance. Moreover, with a revenue growth of 7.94% for the last twelve months as of Q1 2024, AdaptHealth is showing an upward trend in its financials.

For those seeking a deeper analysis, InvestingPro offers additional tips on AdaptHealth, and by using the coupon code PRONEWS24, investors can receive an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With these insights, stakeholders can better assess how the company's recent corporate governance enhancements might influence its financial outlook and stock valuation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.